Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines Read more
Aspaveli (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH Read more
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY T-Cell Engager) Read more
iECURE Receives FDA Fast Track Designation for ECUR-506 for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency Read more
Novartis enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline Read more
FDA approves high-concentration, citrate-free formulation of Cyltezo (adalimumab-adbm) injection, Boehringer Ingelheim’s interchangeable biosimilar to Humira Read more
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease Read more
Janssen to adopt Johnson & Johnson brand as the Company celebrates 100 years of operating in the UK Read more